Lung Cancer News and Research

Latest Lung Cancer News and Research

Researchers develop cancer-killing 'grenades’

Researchers have developed cancer drug-packed 'grenades' armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours, according to two studies due to be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

31 Oct 2015

CarePoint Health – Bayonne Medical Center named ACR-designated center for lung cancer screening

CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.

31 Oct 2015

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Analysis of tumor RNA carried in platelets - blood components best known for their role in clotting - may prove to be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.

31 Oct 2015

Low-dose occupational radiation exposure increases solid cancer risk

Results of the International Nuclear Workers Study suggest a linear increase in incidence of solid cancers with increasing exposure to radiation.

30 Oct 2015

University of Kansas professor recognized with MERIT Award

Emily Scott, professor of medicinal chemistry at the University of Kansas, has been recognized with a MERIT Award from the National Institutes of Health's National Institute of General Medical Sciences. It's a rare and important recognition -- researchers can receive them only once in a career.

30 Oct 2015

Incidence of breast cancer among African American women is increasing

Breast cancer statistics published this week indicate a continuing upward trend for rates of breast cancer among African American women in the United States. The incidence of breast cancer in this population of women who have historically had low rates of breast cancer is now approaching that seen among white women.

30 Oct 2015

Halozyme Therapeutics announces initiation of rivipansel Phase 1 clinical trial

Halozyme Therapeutics, Inc. today announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of a subcutaneous formulation of rivipansel, a compound discovered by GlycoMimetics, Inc. and being developed by Pfizer Inc., using Halozyme's ENHANZE formulation.

30 Oct 2015

Breast cancer rates continue to increase among African American women

Breast cancer rates among African American women in the United States have continued to increase, converging with rates among white women and closing a gap that had existed for decades. The finding is part of Breast Cancer Statistics, 2015, published in CA: A Cancer Journal for Clinicians, and its accompanying consumer publication, Breast Cancer Facts & Figures.

30 Oct 2015

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

The New York Stem Cell Foundation announced today that Franziska Michor, PhD, is the 2015 recipient of the NYSCF - Robertson Stem Cell Prize for her work pioneering new approaches to study the growth, spread, and treatment of cancer. Her laboratory fuses her passions in mathematics, molecular biology and patient care to investigate how cancers form and progress.

29 Oct 2015

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.

28 Oct 2015

Entry of eleven novel therapies expected to drive NSCLC market's growth to $12.7 billion in 2024

Decision Resources Group finds that the entry of eleven novel therapies into the non-small-cell lung cancer (NSCLC) market will drive the market's growth from $5.4 billion in 2014 to $12.7 billion in 2024.

27 Oct 2015

Unique, tiny protein cage developed to deliver chemotherapy chemicals directly to cancer cells

Washington State University researchers have developed a unique, tiny protein cage to deliver nasty chemotherapy chemicals directly to cancer cells. Direct delivery could improve treatment and lessen what can be horrendous side effects from toxic drugs.

27 Oct 2015

Study: Reduction in Amazon deforestation improves air quality, prevents premature deaths

Because of decreasing deforestation and emissions from forest fires in the Amazon over the past ten years, the amount of particulate matter (aerosols), ozone, carbon monoxide, nitrogen oxide and other atmospheric pollutants released by burning biomass has fallen by 30% on average during the dry season in southern Brazil, Paraguay, northern Bolivia and Argentina.

27 Oct 2015

New approaches to treating lung cancer patients in New Mexico

This year, more than 158,000 Americans are expected to die from lung cancer. That's a staggering number: it's more than all the deaths expected from breast, prostate, colon, rectum, bladder and skin cancers combined.

26 Oct 2015

UW researchers develop new model to more accurately predict harmful genetic mutations

Between any two people, there are likely to be at least 10 million differences in the genetic sequence that makes up their DNA.

26 Oct 2015

Nivolumab vs docetaxel updated results for nonsquamous, squamous NSCLC

Follow-up results from two trials of the programmed death 1 receptor inhibitor nivolumab versus docetaxel in patients with advanced non-small cell lung cancer were reported at a proffered paper session held at the European Cancer Congress in Vienna, Austria.

23 Oct 2015

New joint initiative to explore clinical interpretation of molecular tests for cancers

A new conference helping doctors navigate one of the most important scientific questions faced by the cancer community could help improve survival rates for patients.

23 Oct 2015

Early trial results in lung cancer

Results from early phase trials investigating different therapeutic agents in lung cancer patients were presented during the third Presidential Session at the European Cancer Congress in Vienna, Austria. Here we summarise two studies reported at the session.

22 Oct 2015

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Henry Ford Hospital pulmonologist Daniel Ouellette, M.D., who during his 31-year career in medicine has seen the harmful effects of smoking on his patients, advocates for raising the smoking age to 21.

22 Oct 2015

Quest Diagnostics announces net income of $342 million for third quarter of 2015

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the quarter ended September 30, 2015, adjusted net income was $172 million compared to $161 million for 2014. Adjusted diluted EPS excluding amortization was $1.28 in the third quarter of 2015, compared to $1.20 in 2014.

From Quest Diagnostics 22 Oct 2015

Lung Cancer News and Research

Latest Lung Cancer News and Research

Researchers develop cancer-killing 'grenades’

CarePoint Health – Bayonne Medical Center named ACR-designated center for lung cancer screening

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Low-dose occupational radiation exposure increases solid cancer risk

University of Kansas professor recognized with MERIT Award

Incidence of breast cancer among African American women is increasing

Halozyme Therapeutics announces initiation of rivipansel Phase 1 clinical trial

Breast cancer rates continue to increase among African American women

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

Entry of eleven novel therapies expected to drive NSCLC market's growth to $12.7 billion in 2024

Unique, tiny protein cage developed to deliver chemotherapy chemicals directly to cancer cells

Study: Reduction in Amazon deforestation improves air quality, prevents premature deaths

New approaches to treating lung cancer patients in New Mexico

UW researchers develop new model to more accurately predict harmful genetic mutations

Nivolumab vs docetaxel updated results for nonsquamous, squamous NSCLC

New joint initiative to explore clinical interpretation of molecular tests for cancers

Early trial results in lung cancer

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Quest Diagnostics announces net income of $342 million for third quarter of 2015

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in